Skip to main content

Advertisement

Log in

Medical therapy for chronic pancreatitis pain

  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

Chronic pancreatitis should be considered in all patients with unexplained abdominal pain. Management of abdominal pain in these patients continues to pose a formidable challenge. The importance of small duct disease without radiographic abnormalities is now a well-established concept. It is meaningful to determine whether patients with chronic pancreatitis have small duct or large duct disease because this distinction has therapeutic implications. Diagnostic evaluation should begin with simple noninvasive and inexpensive tests like serum trypsinogen and fecal elastase, to be followed where appropriate by more complicated measures such as the secretin hormone stimulation test, especially in patients with suspected small duct disease. No universal causal treatment is available. Non-enteric-coated enzyme preparations are useful for treatment of pain, whereas enteric-coated enzyme preparations are preferred for steatorrhea. Octreotide is used increasingly for abdominal pain that is unresponsive to pancreatic enzyme therapy. When medical therapy for chronic pancreatitis pain has failed, endoscopic therapy, endoscopic ultrasound-guided celiac plexus block, and thoracoscopic splanchnicectomy, performed by experts, may be considered for a highly selected patient population. Surgical ductal decompression is appropriate in patients with considerable pancreatic ductal dilation. The role and efficacy of cholecystokinin-receptor antagonists, antioxidants, and antidepressant drugs remain to be defined.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Toskes PP, Greenberger NJ: Approach to the patient with pancreatic disease. In Harrison’s Principles of Internal Medicine, edn 15. Edited by Braunwald E, Fauci AS, Kasper DL, et al. New York: McGraw Hill; 2001:1788–1792.

    Google Scholar 

  2. Greenberger NJ, Toskes PP: Acute and chronic pancreatitis. In Harrison’s Principles of Internal Medicine, edn 15. Edited by Braunwald E, Fauci AS, Kasper DL, et al. New York: McGraw Hill; 2001:1792–1804.

    Google Scholar 

  3. Toskes PP: Update on diagnosis and management of chronic pancreatitis [review]. Curr Gastroenterol Rep 1999 1:145–153.

    Article  Google Scholar 

  4. Walsh TN, Rode J, Theiss BA, Russel RCC: Minimal change chronic pancreatitis. Gut 1992, 33:1566–1571.

    PubMed  CAS  Google Scholar 

  5. Whitcomb DC, Garry MC, Preston RA, et al.: Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996, 14:141–145

    Article  PubMed  CAS  Google Scholar 

  6. Cohn JA, Friedman KJ, Noone DG, et al.: Relation between mutation of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 1998, 339:653–658

    Article  PubMed  CAS  Google Scholar 

  7. Freiss H, Yamanaka Y, Buchler M, et al.: Increased expression of acidic and basic fibroblast growth factors in chronic pancreatitis. Am J Pathol 1994, 144:117–128.

    Google Scholar 

  8. Di Sebastiano P, di Mola FF, Di Febbo C, et al.: Expression of interleukin 8 (IL-8) and substance P in human chronic pancreatitis. Gut 2000, 47:423–428.

    Article  PubMed  Google Scholar 

  9. Chey WY: Neurohormonal control of the exocrine pancreas. Curr Opin Gastroenterol 1997, 13:375–380

    Article  CAS  Google Scholar 

  10. Draganov P, Toskes PP: Chronic pancreatitis. Curr Opin Gastroenterol 2002, 18:558–562. A succinct review of the controversial areas in chronic pancreatitis with an emphasis on small duct disease.

    Article  PubMed  CAS  Google Scholar 

  11. Forsmark CE, Toskes PP: What does an abnormal pancreatogram mean [review]? Gastrointest Endosc Clin N Am 1995, 5:105–123.

    PubMed  CAS  Google Scholar 

  12. Chowdhury R, Forsmark CE, Toskes PP, et al: The evaluation of unexplained pain of presumed pancreatic origin [abstract]. Gastroenterology 2001, A-760:120.

    Google Scholar 

  13. Verne GN, Chowdhury R, Toskes PP: Prevalence of gastroparesis in patients with small duct chronic pancreatitis. Pancreas 2003, in press.

  14. Greenberger NJ: Enzymatic therapy in patients with chronic pancreatitis [review]. Gastroenterol Clin North Am 1999, 28:687–693

    Article  PubMed  CAS  Google Scholar 

  15. Slaff JI, Wolfe MM, Toskes PP: Elevated fasting cholecystokinin levels in pancreatic exocrine impairment: evidence to support feedback regulation. J Lab Clin Med 1985, 105:282–285.

    PubMed  CAS  Google Scholar 

  16. Mossner J: Palliation of pain in chronic pancreatitis: use of enzymes [abstract]. Surg Clin North Am 1999, 79:861–872.

    Article  PubMed  CAS  Google Scholar 

  17. Smyth RI, Van Velzen D, Smyth AR, et al.: Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet 1994, 343:85–86.

    Article  PubMed  CAS  Google Scholar 

  18. Warshaw AL, Banks PA, Fernandez-Del Castillo C: AGA technical review: treatment of pain in chronic pancreatitis. Gastroenterology 1998, 115:765–776.

    Article  PubMed  CAS  Google Scholar 

  19. Isaksson G, Ihse I: Pain reduction by an oral pancreatic enzyme preparation in chronic pancreatitis. Dig Dis Sci 1983, 28:97–102

    Article  PubMed  CAS  Google Scholar 

  20. Slaff J, Jacobson D, Tillman CR, et al.: Protease-specific suppression of pancreatic exocrine secretion. Gastroenterology 1984, 87:44–52.

    PubMed  CAS  Google Scholar 

  21. Brown A, Hughes M, Tenner S, et al.: Does pancreatic enzyme supplementation reduce pain in patients with chronic pancreatitis: a meta-analysis. Am J Gastroenterol 1997, 92:2032–2035.

    PubMed  CAS  Google Scholar 

  22. Uhl W, Anghelacopoulos SE, Friess H, Buchler MW: The role of octreotide and somatostatin in acute and chronic pancreatitis [review]. Digestion 1999, 60(Suppl 2):23–31.

    Article  PubMed  CAS  Google Scholar 

  23. Malfertheiner P, Mayer D, Buchler M, et al.: Treatment of pain in chronic pancreatitis by inhibition of pancreatic secretion with octreotide. Gut 1995, 36:450–454.

    PubMed  CAS  Google Scholar 

  24. Buchler MW, Binder M, Friess H: Role of somatostatin and its analogues in the treatment of acute and chronic pancreatitis [review]. Gut 1994, 35(Suppl 3):S15-S!9.

    PubMed  CAS  Google Scholar 

  25. Toskes PP, Forsmark CE, DeMeo MT, et al.: A multi-center controlled trial of octreotide for the pain of chronic pancreatitis [abstract]. Pancreas 1993, 8:774.

    Google Scholar 

  26. De las Heras Castano G, Garciade la Paz A, Fernandez MD, Fernandez Forcelledo JL: Use of antioxidants to treat pain in chronic pancreatitis. Rev Esp Enferm Dig 2000, 92:375–385.

    PubMed  Google Scholar 

  27. Uden S, Bilton D, Guyan PM, et al.: Rationale for antioxidant therapy in pancreatitis and cystic fibrosis. Adv Exp Med Biol 1990, 264:555–572.

    PubMed  CAS  Google Scholar 

  28. McCleane GJ: The cholecystokinin antagonist proglumide has an analgesic effect in chronic pancreatitis. Pancreas 2000, 21:324–325.

    Article  PubMed  CAS  Google Scholar 

  29. Toskes PP, Curington C, Cintron M, et al.: Oral administration of the CCK-antagonist MK329.substantiates feedback control of pancreatic secretion in chronic pancreatitis patients [abstract]. Gastroenterology 1990, 98:237.

    Google Scholar 

  30. Shiratori K, Takeuchi T, Satake K, Matsuno S: Clinical evaluation of oral administration of a cholecystokinin-a receptor antagonist (loxiglumide) to patients with acute, painful attacks of chronic pancreatitis: a multicenter dose-response study in Japan. Pancreas 2002, 25:E1-E5. A provocative study suggesting that CCK antagonists may have a role in the management of chronic pancreatitis pain.

    Article  PubMed  Google Scholar 

  31. Rosch T, Daniel S, Scholz M, et al.: Endoscopic treatment of chronic pancreatitis: a multicenter study of 1000 patients with long-term follow-up. Endoscopy 2002, 34:765–771.

    Article  PubMed  CAS  Google Scholar 

  32. Kasmin FE, Siegel JH: Endoscopic therapy for chronic pancreatitis [review]. Surg Clin North Am 2001, 81:421–430.

    Article  PubMed  CAS  Google Scholar 

  33. Binmoeller KF, Rathod VD, Soehendra N: Endoscopic therapy of pancreatic strictures [review]. Gastrointest Endosc Clin North Am 1998, 8:125–142.

    CAS  Google Scholar 

  34. Gress F, Schmitt C, Sherman S, et al.: Endoscopic ultrasoundguided celiac plexus block for managing abdominal pain associated with chronic pancreatitis: a prospective single center experience. Am J Gastroenterol 2001, 96:409–416. A well-done study demonstrating that EUS-guided celiac plexus block may be effective for short-term management of pain in some patients with chronic pancreatitis. Patients aged under 45 years and those with prior pancreatic surgery do not appear to benefit.

    Article  PubMed  CAS  Google Scholar 

  35. Gress F, Schmitt C, Sherman S, et al.: A prospective randomized comparison of endoscopic ultrasound- and computed tomography-guided celiac plexus block for managing chronic pancreatitis pain. Am J Gastroenterol 1999, 94:900–905.

    Article  PubMed  CAS  Google Scholar 

  36. Abedi M, Zfass AM: Endoscopic ultrasound-guided (neurolytic) celiac plexus block. J Clin Gastroenterol 2001, 32:390–393.

    Article  PubMed  CAS  Google Scholar 

  37. Leksowski K: Thoracoscopic splanchnicectomy for the relief of pain due to chronic pancreatitis. Surg Endosc 2001, 15:592–596.

    Article  PubMed  CAS  Google Scholar 

  38. Maher JW, Johlin FC, Heitshusen D: Long-term follow-up of thoracoscopic splanchnicectomy for chronic pancreatitis pain. Surg Endosc 2001, 15:706–709.

    Article  PubMed  CAS  Google Scholar 

  39. Buscher HC, Jansen JB, van Dongen R, et al.: Results of bilateral thoracoscopic splanchnicectomy in patients with chronic pancreatitis. Br J Surg 2002, 89:158–162. A study in 44 patients in which thoracoscopic splanchnicectomy proved effective in decreasing the abdominal pain of chronic pancreatitis. The pain eventually recurred in approximately 50% of patients.

    PubMed  CAS  Google Scholar 

  40. Howell JG, Johnson LW, Sehon JK, Lee WC: Surgical management for chronic pancreatitis. Am Surg 2001, 67:487–490.

    PubMed  CAS  Google Scholar 

  41. Massucco P, Calgaro M, Bertolino F, et al.: Outcome of surgical treatment for chronic calcifying pancreatitis. Pancreas 2001, 22:378–382.

    Article  PubMed  CAS  Google Scholar 

  42. Friess H, Berberat PO, Wirtz M, Buchler MW: Surgical treatment and long-term follow-up in chronic pancreatitis. Eur J Gastroenterol Hepatol 2002, 14:971–977.

    Article  PubMed  Google Scholar 

  43. Sakorafas GH, Farnell MB, Farley DR, et al.: Long-term results after surgery for chronic pancreatitis. Int J Pancreatol 2000, 27:131–142.

    PubMed  CAS  Google Scholar 

  44. Izbicki JR, Bloechle C, Knoefel WT, et al.: Surgical treatment of chronic pancreatitis and quality of life after operation [review]. Surg Clin North Am 1999, 79:913–944.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Singh, V.V., Toskes, P.P. Medical therapy for chronic pancreatitis pain. Curr Gastroenterol Rep 5, 110–116 (2003). https://doi.org/10.1007/s11894-003-0079-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-003-0079-6

Keywords

Navigation